Skip to main content
hpa logo
Topics A-Z:
Search the site:
Home › Topics › Infectious Diseases › Infections A-Z › Fungal Infections › Epidemiological Data ›Candidaemia in England, Wales and Northern Ireland: 2010 Annual Update ›  Candidaemia in England, Wales and Northern Ireland: 2010 - Species-specific data
Printer friendly page (opens in new window)

Candidaemia in England, Wales and Northern Ireland: 2010 - Species-specific data

The percentage of reports in which Candida bloodstream infection was recorded with full species information has remained the same as last year at 94% (table 2).  Of the remainder, Candida albicans was the most frequently reported species in 2010, accounting for 52% of candidaemia reports, with other common species including C. glabrata (24%) and C. parapsilosis (19%). The number and proportion of candidaemia reports which identified C. glabrata has been increasing steadily between 2006 (332) and 2010 (413).

Table 2: Laboratory reports of candidaemia by species; England, Wales, and Northern Ireland: 2007-2010
2007 2008 2009 2010
Species   no. (%) no. (%) no. (%) no. (%)
Candida albicans 1,028 (52%) 938 (52%) 902 (52%) 875 (51%)
Candida famata 2 (0%) 11 (1%) 6 (0%) 5 (0%)
Candida glabrata 383 (19%) 369 (20%) 384 (22%) 413 (24%)
Candida guilliermondii 28 (1%) 16 (1%) 7 (0%) 6 (0%)
Candida kefyr 1 (0%) - (0%) 5 (0%) 11 (1%)
Candida krusei 27 (1%) 25 (1%) 26 (2%) 24 (1%)
Candida lusitaniae 22 (1%) 20 (1%) 27 (2%) 19 (1%)
Candida parapsilosis 197 (10%) 194 (11%) 171 (10%) 157 (9%)
Candida tropicalis 75 (4%) 68 (4%) 63 (4%) 64 (4%)
Candida pelliculosa  3 (0%) - (0%) 1 (0%) 1 (0%)
Candida ciferrii - (0%) 1 (0%) 2 (0%) 4 (0%)
Candida spp. - species not recorded 198 (10%) 134 (7%) 98 (6%) 104 (6%)
Candida spp. - other named 26 (1%) 38 (2%) 34 (2%) 34 (2%)
Total 1,990 (100%) 1,814 (100%) 1,726 (100%) 1,714 (100%)

Source: Health Protection Agency

Reporting to species level is important for monitoring changes in the epidemiology of these infections, with different species being associated with infections in different patient groups and with differing levels of antifungal susceptibility [3].

For assistance with the management of fungal infections, including species identification and confirmation of sensitivity testing results, laboratories can submit isolates to the Mycology Reference Laboratory in Bristol.

 

 

 

 


Last reviewed: 16 September 2011